Celldex Therapeutics reported $0 in Loan Capital for its fiscal quarter ending in March of 2025.




Loan Capital Change Date
AbbVie USD 64.53B 4.19B Mar/2025
Amgen USD 53.76B 253M Jun/2025
Bristol-Myers Squibb USD 44.47B 1.69B Jun/2025
Celldex Therapeutics USD 0 0 Mar/2025
Glaxosmithkline GBP 15.3B 667M Jun/2025
Pfizer USD 57.5B 137M Jun/2025
Roche Holding CHF 32.1B 1.94B Dec/2024